Free Trial

Bicara Therapeutics (BCAX) News Today

Bicara Therapeutics logo
$24.01
+0.33 (+1.39%)
(As of 11/1/2024 ET)
Bicara Therapeutics Inc. stock logo
Bicara Therapeutics (NASDAQ:BCAX) Trading Up 7.9% - What's Next?
Bicara Therapeutics (NASDAQ:BCAX) Trading 7.9% Higher - Time to Buy?
Bicara Therapeutics Inc. stock logo
Bicara Therapeutics Inc.'s Quiet Period Will End on October 23rd (NASDAQ:BCAX)
Bicara Therapeutics' (NASDAQ:BCAX - Get Free Report) quiet period will expire on Wednesday, October 23rd. Bicara Therapeutics had issued 17,500,000 shares in its IPO on September 13th. The total size of the offering was $315,000,000 based on an initial share price of $18.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Bicara Therapeutics Inc. stock logo
Bicara Therapeutics (NASDAQ:BCAX) Sets New 52-Week Low - What's Next?
Bicara Therapeutics (NASDAQ:BCAX) Sets New 52-Week Low - Here's Why
Bicara Therapeutics Inc. stock logo
Bicara Therapeutics Inc. (NASDAQ:BCAX) to Post FY2024 Earnings of ($1.61) Per Share, Cantor Fitzgerald Forecasts
Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Bicara Therapeutics in a note issued to investors on Tuesday, October 8th. Cantor Fitzgerald analyst E. Schmidt expects that
Bicara Therapeutics Inc. stock logo
Bicara Therapeutics (NASDAQ:BCAX) Trading Down 3.5% - What's Next?
Bicara Therapeutics (NASDAQ:BCAX) Stock Price Down 3.5% - Here's Why
Last Week's 3 Biotech IPOs Prompt Huge Insider Buying
Get Bicara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCAX and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

BCAX Media Mentions By Week

BCAX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCAX
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

BCAX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCAX Articles
This Week

0

2

BCAX Articles
Average Week

Get Bicara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCAX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BCAX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners